"GLP-1 medications can be life-changing for some people," she offered
Keep track of any missed doses
Dr Malige pointed to patent timelines and said, Semaglutide will go out of patency in March 2026 after that, leading Indian pharmaceutical companies will manufacture and market semaglutide, which will bring down the cost significantly. $499 in the U.S., 17,000 in India: The Cost of Chasing the Skinny Jab Dream Patent expiry matters
It explains how your body adjusts after stopping the medication
You have a BMI of 30 or higher and you have at least one of these conditions: Diastolic heart failure (also called heart failure with preserved ejection fraction) Uncontrolled high blood pressure (also called hypertension) Chronic kidney disease at stage 3a or higher You have a BMI of 27 or higher and have at least one of these conditions: Prediabetes A previous heart attack (also called myocardial infarction) or stroke Blocked arteries in your legs or arms (also called peripheral artery disease) with symptoms Provider requirements If youre eligible, your doctor or other health care provider must send a prescription for a covered GLP-1 drug to the pharmacy and when requested, complete a prior authorization
10.1038/mp.2017.172 94 OussalahA.JulienM.LevyJ.HajjarO.FranczakC.StephanC.et al (2019)